Key Takeaways
- • Balbec Capital closed its fourth distressed-debt fund, InSolve Global Credit Fund IV, at $1.2 billion in commitments, exceeding its initial $1 billion target and marking the firm's largest fund to date.
- • The fund specializes in non-performing distressed loans across insolvency, restructuring, and liquidation scenarios, positioning Balbec to capitalize on elevated distressed opportunities amid coronavirus-driven economic disruption in mid-2020.
- • Balbec's fund progression demonstrates sustained capital availability for distressed investing: Fund I ($143M in 2012), Fund II ($629M in 2015), Fund III ($727M in 2018), and Fund IV ($1.2B in 2020)—reflecting 738% growth in fund size over eight years.
- • The firm has deployed over $5.2 billion across more than 300 transactions in 19 countries since its 2010 founding, with $2.4 billion in assets under management, indicating institutional-grade scale and diversification across geographies.
- • Strong backing from existing Balbec clients signals confidence in the manager's track record and positions the firm to navigate multiple market cycles, particularly relevant given pandemic-driven consumer and small-to-medium enterprise credit stress.
Summary
Balbec Capital, a specialized alternative asset manager focused on distressed and non-performing credit, has successfully closed InSolve Global Credit Fund IV at $1.2 billion in capital commitments as of June 10, 2020. The fund exceeded its initial target raise of $1 billion and represents the firm's largest investment vehicle to date, according to American Banker's Asset Securitization Report.
The fund's strategy targets a defined subset of Balbec's core competency: non-performing distressed loans within insolvency, restructuring, or liquidation frameworks. The timing of the close coincided with elevated market dislocations caused by the coronavirus outbreak, which generated significant distressed opportunities in both consumer credit and small-to-medium enterprise debt. Charles Rusbasan, Balbec's founding partner and chief executive officer, stated that the firm expects "the pipeline of opportunities to remain robust as we look to build upon our track record of successfully investing across market cycles."
The capital raise reflects sustained investor confidence in Balbec's distressed investment thesis. The fund received "significant backing" from existing Balbec clients, according to company disclosures, underscoring retention of institutional capital and confidence in the manager's execution. This represents a meaningful data point for institutional investors assessing distressed-credit manager quality and investor conviction during volatile periods.
Balbec's fund progression illustrates both the firm's growth trajectory and the expanding institutional appetite for distressed investing over the past decade. InSolve Global Credit Fund I (2012, $143 million), Fund II (2015, $629 million), and Fund III (2018, $727 million) preceded the new vehicle. The $1.2 billion Fund IV reflects approximately 738% growth in fund size across four vintages spanning eight years.
Since its founding in 2010, Balbec has deployed over $5.2 billion across more than 300 transactions spanning 19 countries, with $2.4 billion in assets under management as of the close. This scale and geographic diversification position the firm as an institutional-grade manager within the distressed-credit space, relevant for family offices and hedge funds evaluating exposure to non-performing loan strategies during periods of elevated credit stress.
The fund's strategy targets a defined subset of Balbec's core competency: non-performing distressed loans within insolvency, restructuring, or liquidation frameworks. The timing of the close coincided with elevated market dislocations caused by the coronavirus outbreak, which generated significant distressed opportunities in both consumer credit and small-to-medium enterprise debt. Charles Rusbasan, Balbec's founding partner and chief executive officer, stated that the firm expects "the pipeline of opportunities to remain robust as we look to build upon our track record of successfully investing across market cycles."
The capital raise reflects sustained investor confidence in Balbec's distressed investment thesis. The fund received "significant backing" from existing Balbec clients, according to company disclosures, underscoring retention of institutional capital and confidence in the manager's execution. This represents a meaningful data point for institutional investors assessing distressed-credit manager quality and investor conviction during volatile periods.
Balbec's fund progression illustrates both the firm's growth trajectory and the expanding institutional appetite for distressed investing over the past decade. InSolve Global Credit Fund I (2012, $143 million), Fund II (2015, $629 million), and Fund III (2018, $727 million) preceded the new vehicle. The $1.2 billion Fund IV reflects approximately 738% growth in fund size across four vintages spanning eight years.
Since its founding in 2010, Balbec has deployed over $5.2 billion across more than 300 transactions spanning 19 countries, with $2.4 billion in assets under management as of the close. This scale and geographic diversification position the firm as an institutional-grade manager within the distressed-credit space, relevant for family offices and hedge funds evaluating exposure to non-performing loan strategies during periods of elevated credit stress.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.